Management tracks: Sanofi head of strategy Mansuri set to retire; plus Arrakis, MorphoSys, Kymera, Kronos, Kite, Twist, Cerevel, Coda, Science 37, and more

Sanofi (Euronext:SAN; NASDAQ:SNY) said Muzammil Mansuri, EVP, head of strategy and business development, will retire at the end of the month. His responsibilities will be divided between Alban de La Sablière, head of business development, and Laurent Van Lerberghe, head of strategy.

RNA-targeting company Arrakis Therapeutics Inc. appointed Katrine Bosley as chairman. She was CEO of Editas Medicine Inc. (NASDAQ:EDIT) and serves on the boards of Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG), Massachusetts Eye and Ear and Genocea Biosciences Inc. (NASDAQ:GNCA)...